Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dolby Laboratories (DLB) EBITDA Margin (2016 - 2025)

Dolby Laboratories' EBITDA Margin history spans 17 years, with the latest figure at 17.93% for Q4 2025.

  • For Q4 2025, EBITDA Margin fell 445.0% year-over-year to 17.93%; the TTM value through Dec 2025 reached 18.47%, down 221.0%, while the annual FY2025 figure was 19.64%, 64.0% down from the prior year.
  • EBITDA Margin reached 17.93% in Q4 2025 per DLB's latest filing, up from 9.67% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 29.89% in Q1 2024 to a low of 1.2% in Q3 2023.
  • Average EBITDA Margin over 5 years is 17.91%, with a median of 16.83% recorded in 2022.
  • Peak YoY movement for EBITDA Margin: plummeted -1650bps in 2021, then surged 1641bps in 2024.
  • A 5-year view of EBITDA Margin shows it stood at 25.76% in 2021, then rose by 9bps to 28.09% in 2022, then fell by -25bps to 20.98% in 2023, then grew by 7bps to 22.38% in 2024, then dropped by -20bps to 17.93% in 2025.
  • Per Business Quant, the three most recent readings for DLB's EBITDA Margin are 17.93% (Q4 2025), 9.67% (Q3 2025), and 15.1% (Q2 2025).